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structure and function of this receptor, and to test directly ideas concerning the functional significance of discrete receptor residues on particular aspects of receptor function (see references in the legends to
Figs. 1 and 2). In Figs. 1 and 2 , results derived from the study of a number of such mutations on insulin receptor autophosphorylation, exogenous substrate phosphorylation (PTK activity) and several signalling pathways in intact cells are summarized. At the outset, it should be noted that there are as yet unresolved controversies concerning the phenotypes observed for several mutations, which are likely to derive from experimental limitations inherent in the cell systems utilized thus far in these studies. First, most of the rodent cell lines used for transfection of the human receptor cDNA [e.g. Chinese hamster ovary (CHO), NIH 3T3 and rat1 cells] are not very responsive to insulin, e.g. CHO cells exhibit a 2-fold effect of insulin on glucose transport. Secondly, there is often clonal variation [i.e. between individual clones derived from a stable transfection with a particular cDNA construct (e.g. the basal activity of a particular metabolic response such as insulindependent thymidine uptake may vary between individual stably transfected clones); such elevations in basal activity complicate the interpretation of slight increases in sensitivity observed in insulin dose-response curves; see below]; thus, the study of a number of independently derived clones (or pools of transfected clones) for each construct is required. Thirdly, the analysis is always complicated by the presence of endogenous wild-type insulin receptors found in all the cell lines used to date (typically a few thousand endogenous receptors per cell in the commonly used fibroblast cell lines). The transfection of a heterologous compliment of human wild-type insulin receptors into these cells (levels of -lo4 to -loh receptor per cell are readily obtainable) increases the sensitivity of the transfected cell to insulin (i.e. causes a leftward shift in the insulin dose-response). Thus, one is monitoring often subtle changes in insulin sensitivity above the endogenous response. Furthermore, mutations which compromise (but do not eliminate) receptor signalling, generally cause a loss of this increased insulin sensitivity towards that observed for mock-transfected cells, while cells expressing
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Nucleotide Binding and Hydrolysis There are at present a number of actively debated aspects of insulin receptor function, particularly involving the individual roles of Tyr-1158, -1 162 and -1 163. The phosphorylation of all three tyrosines (to 3 mol of phosphate/mol of sites) has been proposed to correlate with activation of the kinase towards exogenous substrates [ 14, 451. The fact that replacement of Tyr-1162, or both Tyr-11 62 and -1 163, with phenylalanine(s) compromises kinase activation appears, at first sight, to be in general agreement with this proposal. However, while Zhang et al. [5 l] report that replacement of Tyr-1158 with phenylalanine has no affect on insulin-stimulated receptor kinase activation, Wilden et al. [48] report a substantial reduction.
The resolution of this discrepancy is imperative, as
Wilden et al. [48] have proposed that the mutation of Tyr-1158 has opposing effects on insulin-stimulated glycogen synthesis and thymidine uptake compared with those observed in the Tyr-11621 1163 to phenylalanine double mutant (see Fig. 2 ).
Autonomous function by individual domains of the insulin receptor
The first indication that the major functional [I] identified a second previously unidentified mutation in their construct which lies two codons away from tyrosine 972. This resulted in the substitution of Ser-974 with a threonine. At present it is not known whether this affects the interpretation of the data given in this Table. tMutations which were first identified in insulin receptors from human patients. $Data given in parentheses are from Zhang et 01. [5 I] . $This is disputed by Sbraccia et a/. [30] . 1IData in parentheses is from Yonezawa et ol. [50] . llData in parentheses is from Boulton eta/. [2] .
domains of the insulin receptor were in fact capable of autonomous function derived from studies of receptors with a deletion within (or complete removal of) the extracellular ligand-binding domain. Such altered receptors exhibit insulin-independent autophosphorylation and activation of exogenous After these initial observations of autonomous kinase domain function, and the observation that the cytoplasmic PTK could be expressed as a soluble cytoplasmic active enzyme (i.e. the iBgl construct of Fig. l) , the deduced transmembrane topology of the human insulin receptor was formally tested and verified for the extracellular domain as well. Thus, truncation before the hydrophobic stretch of amino acids predicted to comprise the single transmembrane segment of each half-receptor, results in the secretion of a soluble heterotetramer (i.e. a2&, where /lo is the extracellular portion of the membrane-spanning /?-subunit) which binds insulin with high affinity [13, 18, [31] [32] 471 . Given the size (1355 residues per halfreceptor) and membrane-associated nature of the wild-type insulin receptor protein, it has subsequently proven experimentally advantageous to
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Nucleotide Binding and Hydrolysis exploit this relatively simple transmembrane topology of the receptor to engineer and study its two functional domains individually as soluble molecules, i.e. the extracellular domain as a soluble secreted insulin-binding protein, and the cytoplasmic domain as a soluble PTK. The use of these soluble receptor derivatives, together with powehl heterologous cell-expression systems, has now rendered feasible the application of biophysical methods to the studies of these domains, which are still not possible for the native membrane-associated receptor.
The insulin receptor extracellular domain
The extracellular ligand-binding domain of the insulin receptor is, at the outset, a very complex molecule to contemplate: each half-receptor is comprised of 929 residues derived from both a-(735 amino acids) and /3-subunits (194 amino acids), and includes 16 potential asparagine-linked glycosylation sites and 41 cysteines. Furthermore, there is little information at present as to how this domain folds during biosynthesis, or how it interacts with insulin. The study of an extensive series of deletion mutants has revealed sites within the receptor primary sequence at which truncation results in the generation of independently folded soluble subdomains [31]. As we now appreciate the stability, efficiency of secretion and interaction of these subdomains both with insulin and a panel of receptorspecific monoclonal antibodies, these sites now provide landmarks to guide further biochemical and molecular dissections of this complex domain. Furthermore, the establishment of a heterologous cell expression system, from which 10-20 mg of pure Finally, these quantities now render feasible efforts to crystallize this domain, a prequisite for the elucidation of its three-dimensional structure by X-ray crystallography (in collaboration with Wayne Hendrickson, Columbia University). With the quantities of purified enzyme now available, we have begun to utilize 'H-n.m.r. spectroscopy to study the functional properties of this soluble derivative of the cytoplasmic FTK domain of the receptor. These methods provide new experimental avenues by which to explore the interaction of small molecules (metal ions, ATP, peptide substrates) with the enzyme, and have provided the first look at catalysis by a PTK in real time. We can now follow the binding of peptide substrates to the enzyme, the phosphorylation of individual tyrosine residues of such peptides (especially the order of phosphorylation of multiple tyrosines), as well as study the role of individual amino acid residues of the peptide on its binding to the enzyme and its kinetics of phosphorylation [9, 191 . For example, the proton resonances of each of the three tyrosines of the synthetic peptide RRDIYETDYYRK, which is derived from the receptor sequence around the three major sites of autophosphorylation [i.e. Tyr-1162 (residue 5 of the peptide), Tyr-1162 (residue 9) and Tyr-1163 (residue lo)], are distinguishable in the aromatic region of 'H-n.m.r. spectra. Thus, it is feasible to follow directly, in solution and in real time, the phosphorylation at each site. Furthermore, not only is each of the three tyrosines phosphorylated, but phosphorylation of the peptide is highly ordered and progressive. First Tyr-9, then Tyr-10
The insulin receptor PTK domain
and finally Tyr-5 is phosphorylated, with phosphorylation proceeding to completion at each site before phosphorylation of the next site begins [19] . On the basis of these observations, it is clear that it is now feasible to explore in detail the stereochemical requirements and dynamics of exogenous peptide phosphorylation by this enzyme (B. A.
Levine & L. Ellis, unpublished work).
A logical extension of the n.m.r. studies of peptide phosphorylation by the enzyme is to assess the utility of this method to perhaps visualize autophosphorylation of the enzyme per se. This is a formidable technical undertaking at present: the 401 residue enzyme is significantly larger than other proteins for which two-, three-and now fourdimensional n.m.r. methods have been applied to date, and at least six tyrosines of the kinase can be PTK phosphorylation in solution in real time. These functional studies of the enzyme in solution complement efforts to obtain the three-dimensional structure of the enzyme by X-ray crystallography (in collaboration with Wayne Hendrickson, Columbia University).
Summary
Six years have now elapsed since efforts to establish heterologous cell expression systems for studies of the human insulin receptor were begun. As is apparent from the results summarized in Figs. 1 and 2, a significant number of studies have been devoted to the analysis of receptor mutations, both experimentally derived (i.e. by mutagenesis) and those identified in human patients, as well as to the generation of soluble derivatives of the major functional domains of the receptor for use in biophysical studies. While it is certainly clear that these methods can be expected to yield an ever-increasing body of data concerning insulin receptor structure/function, it is equally apparent that attention to a number of basic experimental limitations inherent in these approaches (see above) will be required to resolve a number of fundamental questions and disagreements concerning particular receptor mutations. Given the level of interest in the insulin receptor that has persisted over the past several decades, one expects that these efforts will be forthcoming, and that our understanding of this complex transmembrane receptor will, with time, improve.
We 
Introduction
The protein products of the N-, K-and Ha-ras genes, termed p21", form part of a family of low molecular mass guanine-nucleotide-binding proteins which have high sequence homology [ 1-41.
They bind GTP and GDP tightly and have low intrinsic GTPase activity. p21 rm proteins have been extensively studied because some single point mutants are found in a high proportion of cancers.
In common with other GTPases, they appear to exist in a biologically active conformation when bound to GTP, and hydrolysis to the GDP complex causes deactivation of the biological effect. Their physiological role, however, is not known. By analogy with the heterotrimeric G-proteins, it has been generally assumed that they form part of a signal-transducing pathway, transmitting a signal from a cell-surface receptor to an intracellular effector molecule, although it has recently been suggested that they may mediate the assembly of macromolecular complexes in membranes [ 31.
To understand the mechanisms by which the concentrations of active and inactive complexes of p21" are regulated in the cell, we are investigating the elementary steps of the p2lr0" GTPase in solution. We aim to define the important intermediates in the process, measure their rates of interconversion and monitor at which stages structural changes occur which may be related to biological activity. This work complements the X-ray diffraction studies of crystals of p21 which have defined structural differences between the GTP-and GDPbound forms of p21" and between normal and transforming mutants [S, 61, and will form a basis for understanding how other cellular components Abbreviations used: GAP, GTPase-activating protein; mant, 2'( 3')-0-( N-methy1)anthraniloyl; DTT, dithiothreitol.
such as the GTPase-activating protein (GAP) regulate the GTPase cycle.
Most studies, including our own, have been on p21" expressed in Escherichziz coli without the post-translational modifications which occur in vivo [7] . Unless otherwise stated, all of the work described is on p21N-". The basis of our kinetic approach is to use well-defined nucleotide complexes of p21 in the absence of excess nucleotide, so that processes of interest occur under single-turnover conditions. The advantage of this approach is that observed rate constants are independent of the concentration of native p21 rm, a value usually based on filter-binding assays which are subject to systematic errors [8] .
Basic GTPase mechanism
The simplest scheme for the hydrolysis of GTP by p21 rm is shown in scheme 1 where R is p2 I rm, R $-GTP R + GDP (scheme 1)
The rate constants, or limits on them, have been measured for the wild-type protein (Gly-12) and two oncogenic mutant proteins (Asp-12 and Val-12). The experimental details and rate constants for the Gly-12 and Asp-12 proteins are given in Neal et al. [9] , and rate constants for all three proteins are summarized in Table 1 . The values of the rate constants show that it is not possible to form p21"eGTP in vitro by simply incubating p21"mGDP with excess GTP under these conditions, since the rate constants of GDP release and GTP cleavage are sufficiently close for significant hydrolysis to occur during the time course of the exchange reaction.
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